GLP-1 injections

Compounded drugs are not FDA-approved or evaluated for safety, efficacy, or quality. Nurx compounded drug offerings are only available in select states.

Medication cost may vary based on prescribed treatment and applicable insurance coverage, price not guaranteed. Not all insurance plans are accepted. Medication shipped and billed monthly. Additional costs apply, including consultation, ongoing care, and side effect management. 

◊Services, not offered in every state, include medical treatment of overweight and obesity including lifestyle counseling (e.g., diet and exercise) and prescription medications, if clinically appropriate, based on completion of  required consultation. Nurx requires regular check-ins to monitor your progress.  Weight loss may be associated with other symptoms including but not limited to muscle loss, fatigue, menstrual changes, gallstones, and mood changes. Extreme/rapid weight loss may result in nutritional deficiencies that lead to hair loss, anemia, weak bones or increased risk of infection. Talk to your provider immediately about symptoms. Many people with overweight or obesity who lose weight have a tendency to regain all or some of the weight over time. Overweight and obesity medication efficacy increases with the addition of diet and exercise. Individual response to treatment may vary and is not guaranteed by Nurx.

1 Important drug safety and benefits information on semaglutide (1mg/ml and 2.4mg/ml injection for subcutaneous use, an Rx only compound drug, can be found here. Semaglutide has not been FDA-approved or evaluated for safety, efficacy, or quality but can be used for weight loss. It may cause side effects including nausea, diarrhea, vomiting, and constipation. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch  or call 1-800-FDA-1088.

2 Zepbound^® single-dose vials and associated materials are shipped and billed separately by Gifthealth. Insurance not accepted, cash pay only. Zepbound® (Tirzepatide) subcutaneous injections, Rx only, combined with a reduced-calorie diet and exercise helps to reduce excess body weight and maintain weight reduction in adults with obesity or overweight and at least one weight-related condition, as well as moderate to severe obstructive sleep apnea.  This drug may cause side effects, including nausea/vomiting, diarrhea, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, gas, hair loss, GERD, abdominal distenision, dizziness and low blood pressure. You should not take Zepbound® if you have a known hypersensitivity to tirzepatide or if you or a family member has been diagnosed with Multiple Endocrine Neoplasia Type 2 or Medullary Thyroid Cancer.  Zepbound® may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, and worsening of diabetic retinopathy if you have type 2 diabetes.  If you would like to learn more, see full prescribing information here. You are encouraged to report negative side effects to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

3 Wegovy® subcutaneous injection is an  Rx only, helps to reduce excess body weight and maintain weight reduction in adults with obesity  and adults with overweight and at least one weight-related condition. It is also indicated to reduce the risk of major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease. This drug may cause side effects, including nausea/vomiting, change in bowel movements, including diarrhea or constipation, abdominal pain, headache, and fatigue. You should not take Wegovy® if you or a family member has been diagnosed with Multiple Endocrine Neoplasia Type 2 or Medullary Thyroid Cancer. Wegovy® may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglyceia, acute kidney injury, severe GI side effects, and an increased risk for worsening of diabetic retinopathy in people with type 2 diabetes.  If you would like to learn more, see full prescribing information here. You are encouraged to report negative side effects to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

4 Saxenda® subcutaneous injection, Rx only, helps with chronic weight management in adults with obesity or overweight and one weight-related condition as an adjunct to a reduced-calorie diet and exercise. This drug may cause side effects, including nausea/vomiting, diarrhea, constipation, headache, and dyspepsia.   You should not take Saxenda® if you are pregnant or if you or a family member has been diagnosed with Multiple Endocrine Neoplasia Type 2 or Medullary Thyroid Cancer. Saxenda® may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, increased heart rate, abdominal pain, reflux, gas and dizziness. If you would like to learn more, see full prescribing information here . You are encouraged to report negative side effects to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

5 Ozempic® subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity and overweight. However, studies have shown that it may be associated with weight loss in individuals with type 2 diabetes.  This drug may also cause side effects nausea/vomiting, diarrhea, abdominal pain, and constipation.  You should not take Ozempic® if you or a family member has been diagnosed with Multiple Endocrine Neoplasia Type 2 or Medullary Thyroid Cancer. Ozempic®  may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglyceia, acute kidney injury, severe GI side effects, and an increased risk for worsening of diabetic retinopathy in people with type 2 diabetes. See more information, here. By providing this content, Thirty Madison, Inc. in no way supports or endorses the use of this product for such condition(s). Only a licensed clinician may prescribe this drug for this condition if in their clinical judgment use of the product is medically appropriate. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

6 Mounjaro® subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity or overweight, however studies have shown that it may be associated with weight loss in individuals with type 2 diabetes. This drug may cause side effects, including nausea/vomiting, diarrhea, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, gas, hair loss, GERD, abdominal distension, dizziness, and low blood pressure. You should not take Mounjaro® if you have a known hypersensitivity to tirzepatide or if you or a family member has been diagnosed with Multiple Endocrine Neoplasia Type 2 or Medullary Thyroid Cancer.  Mounjaro®  may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, worsening of diabetic retinopathy if you have type 2 diabetes.   See more information  here. By providing this content, Thirty Madison, Inc. in no way supports or endorses the use of this product for such condition(s). Only a licensed clinician may prescribe this drug for this condition if in their clinical judgment use of the product is medically appropriate. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

7 Victoza® subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity and overweight; however, studies have shown that it may be associated with weight loss in individuals with type 2 diabetes.  This drug may also cause side effects, including nausea/vomiting, diarrhea, constipation, headache and dyspepsia.   You should not take Victoza®  if you are pregnant or if you or a family member has been diagnosed with Multiple Endocrine Neoplasia Type 2 or Medullary Thyroid Cancer.  Victoza® may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, increased heart rate, abdominal pain, reflux, gas and dizziness .  See more information  here.By providing this content, Thirty Madison, Inc. in no way supports or endorses the use of this product for such condition(s). Only a licensed clinician may prescribe this drug for this condition if in their clinical judgment use of the product is medically appropriate. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

§The information provided here is not a substitute for professional medical advice, diagnosis, or treatment. You should not rely upon the content provided here for specific medical advice. If you have any questions or concerns, please talk to your provider.
Nurx weight management compound drug offerings are only available in select states.

†Lilly has not authorized the content of this advertisement.